News & Updates
Showing Multidisciplinary articles
Showing

Rituximab-temozolomide-radiation combo shows promise in recurrent primary CNS lymphoma
Use of rituximab, temozolomide, and radiation appears safe and effective as salvage therapy for patients with recurrent or refractory primary central nervous system (CNS) lymphoma, according to a study in the Philippines, the results of which were presented at the recent AAN 2023.

Toripalimab plus bevacizumab, SoC demonstrates promising efficacy for cervical cancer
Preliminary results of a single-arm, open-label, phase II trial demonstrated the efficacy of a combination regimen comprising toripalimab, bevacizumab, and platinum-based chemotherapy for women with refractory, recurrent, or metastatic cervical cancer.

Vigorous hydration prevents post-ERCP pancreatitis
Vigorous periprocedural hydration (vHR) appears to be as effective as postprocedure per-rectal indomethacin for the prevention of postendoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP), a study has shown.





